surmount trial tirzepatide Effect of in SURMOUNT-1 trial. (BMI: body mass index; CI: Semaglutide vs. Tirzepatide for Obesity
Description
Retatrutide was associated with a greater increase in resting heart rate than tirzepatide in clinical trials
In comparison, Semaglutide resulted in a 13.7% reduction, or about 33.1 pounds (15.0 kg)
Rated 5 out of 5 Anonymous (verified owner) I have lost quite a bit of weight, along with keeping it, off using citizen meds tirzepitide
The combined effect of GIP and GLP-1 receptor activation is synergistic, producing results greater than what either pathway achieves alone
Use them within 21 days of removing from refrigeration
Editors note Prices are accurate at the time of publication
